Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer

Brain metastases remain a critical issue in the management of non-small cell lung cancer (NSCLC) because of the high frequency and poor prognosis, with survival rates often measured in just months. The local treatment approach remains the current standard of care, but management of multiple asymptom...

Full description

Bibliographic Details
Main Authors: Likui Fang, Wuchen Zhao, Bo Ye, Da Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
brain metastases
immune checkpoint inhibitors
anti-angiogenesis
combination therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.670313/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.670313/full

Similar Items